FOCLIVIA

This brand name is authorized in Austria, Croatia, Estonia, Ireland, Italy, Lithuania, Poland.

Active ingredients

The drug FOCLIVIA contains one active pharmaceutical ingredient (API):

1
 
Read more about Influenza, inactivated, surface antigen

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J07BB02 Influenza, purified antigen J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BB Influenza vaccines
Discover more medicines within J07BB02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
EE Ravimiamet 1451191, 1451203, 1451214, 1451269
IT Agenzia del Farmaco 048369058, 048369060
LT Valstybinė vaistų kontrolės tarnyba 1051380, 1051381, 1086942, 1086943, 1086944, 1086945
PL Rejestru Produktów Leczniczych 100309757

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈